Green tea epigallocatechin-3-gallate mediates T cellular NF-κB inhibition and exerts neuroprotection in autoimmune encephalomyelitis

Journal of Immunology

Volumn 173, Issue 9, 2004, Pages 5794-5800

  Aktas, Orhan ^a   Prozorovski, Timour ^a   Smorodchenko, Alina ^a   Savaskan, Nicolai E ^b   Lauster, Roland ^c   Kloetzel, Peter Michael ^a   Infante Duarte, Carmen ^a   Brocke, Stefan ^d   Zipp, Frauke ^a,e  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c German Arthritis Research Center   (Germany)

^d HEBREW UNIVERSITY   (Israel)

^e Neuroscience Research Center   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

20S PROTEASOME; 26S PROTEASOME; CD4 ANTIGEN; CYCLIN DEPENDENT KINASE 4; EPIGALLOCATECHIN GALLATE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELIN; N METHYL DEXTRO ASPARTIC ACID; PROTEASOME; PROTEOLIPID PROTEIN; PROTEOLIPID PROTEIN 139 151; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN DISEASE; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; DISABILITY; DISEASE SEVERITY; DOWN REGULATION; EFFECTOR CELL; ENCEPHALITIS; HUMAN; HUMAN CELL; INFLAMMATION; MOUSE; MULTIPLE SCLEROSIS; NERVE CELL; NERVE CELL DEGENERATION; NERVE CELL LESION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TEA;

EID: 6344274849     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.9.5794     Document Type: Article

References (35)

1. Mukhtar, H., and N. Ahmad. 1999. Green tea in chemoprevention of cancer. Toxicol. Sci. 52:111.
2. Suganuma, M., S. Okabe, N. Sueoka, E. Sueoka, S. Matsuyama, K. Imai, K. Nakachi, and H. Fujiki. 1999. Green tea and cancer chemoprevention. Mutat. Res. 428:339.
3. Yang, G. Y., J. Liao, K. Kim, E. J. Yurkow, and C. S. Yang. 1998. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 19:611.
4. Liang, Y. C., S. Y. Lin-Shiau, C. F. Chen, and J. K. Lin. 1999. Inhibition of cyclin-dependent kinases 2 and 4 activities as well as induction of Cdk inhibitors p21 and p27 during growth arrest of human breast carcinoma cells by (-)-epigallocatechin-3-gallate. J. Cell. Biochem. 75:1.
5. Lu, Y. P., Y. R. Lou, J. G. Xie, Q. Y. Peng, J. Liao, C. S. Yang, M. T. Huang, and A. H. Conney. 2002. Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UVB-induced skin tumors in mice. Proc. Natl. Acad. Sci. USA 99:12455.
6. Yang, F., W. J. de Villiers, C. J. McClain, and G. W. Varilek. 1998. Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J. Nutr. 128:2334.
7. Dona, M., I. Dell'Aica, F. Calabrese, R. Benelli, M. Morini, A. Albini, and S. Garbisa. 2003. Neutrophil restraint by green tea: inhibition of inflammation, associated angiogenesis, and pulmonary fibrosis. J. Immunol. 170:4335.
8. Lee, S., S. Suh, and S. Kim. 2000. Protective effects of the green tea polyphenol (-)-epigallocatechin gallate against hippocampal neuronal damage after transient global ischemia in gerbils. Neurosci. Lett. 287:191.
9. Levites, Y., O. Weinreb, G. Maor, M. B. Youdim, and S. Mandel. 2001. Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration. J. Neurochem. 78:1073.
10. Steinman, L. 2001. Multiple sclerosis: a two-stage disease. Nat. Immunol. 2:762.
11. Brosnan, C. F., and C. S. Raine. 1996. Mechanisms of immune injury in multiple sclerosis. Brain Pathol. 6:243.
12. Steinman, L. 1999. Assessment of animal models for MS and demyelinating disease in the design of rational therapy. Neuron 24:511.
13. Trapp, B. D., J. Peterson, R. M. Ransohoff, R. A. Rudick, S. Mork, and L. Bo. 1998. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 338:278.
14. Bjartmar, C., J. R. Wujek, and B. D. Trapp. 2003. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J. Neurol. Sci. 206:165.
15. Diestel, A., O. Aktas, D. Hackel, I. Hake, S. Meier, C. S. Raine, R. Nitsch, F. Zipp, and O. Ullrich. 2003. Activation of microglial poly(ADP-ribose)-polymerase-1 by cholesterol breakdown products during neuroinflammation: a link between demyelination and neuronal damage. J. Exp. Med. 198:1729.
16. Zamvil, S. S., and L. Steinman. 2003. Diverse targets for intervention during inflammatory and neurodegenerative phases of multiple sclerosis. Neuron 38: 685.
17. Aktas, O., S. Waiczies, A. Smorodchenko, J. Dorr, B. Seeger, T. Prozorovski, S. Sallach, M. Endres, S. Brocke, R. Nitsch, and F. Zipp. 2003. Treatment of relapsing paralysis in experimental encephalomyelitis by targeting Th1 cells through atorvastatin. J. Exp. Med. 197:725.
18. Lünemann, J. D., S. Waiczies, S. Ehrlich, U. Wendling, B. Seeger, T. Kamradt, and F. Zipp. 2002. Death ligand TRAIL induces no apoptosis but inhibits activation of human (auto)antigen-specific T cells. J. Immunol. 168:4881.
19. Ullrich, O., A. Diestel, I. Eyupoglu, and R. Nitsch. 2001. Regulation of microglial expression of integrins by poly(ADP-ribose) polymerase-1. Nat. Cell. Biol. 3:1035.
20. Savaskan, N. E., A. U. Brauer, M. Kuhbacher, I. Y. Eyupoglu, A. Kyriakopoulos, O. Ninnemann, D. Behne, and R. Nitsch. 2003. Selenium deficiency increases susceptibility to glutamate-induced excitotoxicity. FASEB J. 17:112.
21. Dörr, J., S. Waiczies, U. Wendling, B. Seeger, and F. Zipp. 2002. Induction of TRAIL-mediated glioma cell death by human T cells. J. Neuroimmunol. 122:117.
22. 3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 19:1771.
23. Chow, H. H., Y. Cai, D. S. Alberts, I. Hakim, R. Dorr, F. Shahi, J. A. Crowell, C. S. Yang, and Y. Hara. 2001. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E. Cancer Epidemiol. Biomarkers Prev. 10:53.
24. Barnes, P. J., and M. Karin. 1997. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336:1066.
25. Nitsch, R., I. Bechmann, R. A. Deisz, D. Haas, T. N. Lehmann, U. Wendling, and F. Zipp. 2000. Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL). Lancet 356:827.
26. Hu, W. H., H. Johnson, and H. B. Shu. 1999. Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-κB and JNK activation and apoptosis through distinct pathways. J. Biol. Chem. 274:30603.
27. Wei, H., X. Zhang, J. F. Zhao, Z. Y. Wang, D. Bickers, and M. Lebwohl. 1999. Scavenging of hydrogen peroxide and inhibition of ultraviolet light-induced oxidative DNA damage by aqueous extracts from green and black teas. Free Radical Biol. Med. 26:1427.
28. Haqqi, T. M., D. D. Anthony, S. Gupta, N. Ahmad, M. S. Lee, G. K. Kumar, and H. Mukhtar. 1999. Prevention of collagen-induced arthritis in mice by a polyphenolic fraction from green tea. Proc. Natl. Acad. Sci. USA 96:4524.
29. Hilliard, B. A., N. Mason, L. Xu, J. Sun, S. E. Lamhamedi-Cherradi, H. C. Liou, C. Hunter, and Y. H. Chen. 2002. Critical roles of c-Rel in autoimmune inflammation and helper T cell differentiation. J. Clin. Invest. 110:843.
30. Wang, X., H. Luo, H. Chen, W. Duguid, and J. Wu. 1998. Role of proteasomes in T cell activation and proliferation. J. Immunol. 160:788.
31. 1,-to-S-phase transition. Mol. Cell Biol. 19:2690.
32. Nam, S., D. M. Smith, and Q. P. Dou. 2001. Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J. Biol. Chem. 276:13322.
33. MacMicking, J. D., D. O. Willenborg, M. J. Weidemann, K. A. Rockett, and W. B. Cowden. 1992. Elevated secretion of reactive nitrogen and oxygen intermediates by inflammatory leukocytes in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells. J. Exp. Med. 176:303.
34. Pisters, K. M., R. A. Newman, B. Coldman, D. M. Shin, F. R. Khuri, W. K. Hong, B. S. Glisson, and J. S. Lee. 2001. Phase I trial of oral green tea extract in adult patients with solid tumors. J. Clin. Oncol. 19:1830.
35. Kira, J. 2003. Multiple sclerosis in the Japanese population. Lancet Neurol. 2:117.